BioLife Solutions
BLFS
164 hedge funds and large institutions have $797M invested in BioLife Solutions in 2022 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 72 increasing their positions, 43 reducing their positions, and 34 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 43
0.38% more ownership
Funds ownership: 84.06% → 84.44% (+0.38%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 169 → 164 (-5)
12% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 34
39% less capital invested
Capital invested by funds: $1.31B → $797M (-$508M)
84% less call options, than puts
Call options by funds: $180K | Put options by funds: $1.12M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$14.1M |
| 2 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$4.96M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$4.61M |
| 4 |
FAM
Fred Alger Management
New York
|
+$4.11M |
| 5 |
Two Sigma Investments
New York
|
+$2.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$12.1M |
| 2 |
Jennison Associates
New York
|
-$10.9M |
| 3 |
SLG
Stanley-Laman Group
Berwyn,
Pennsylvania
|
-$9.64M |
| 4 |
E
Ergoteles
New York
|
-$2.62M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.5M |
BLFS Hedge Fund Activity: Q1 2022 in Review
164 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q1 2022, worth a combined $797M — down 39% from $1.31B a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of BLFS and 30 opened new positions — a net loss of 4 holders — while 43 trimmed existing stakes and 72 added.
The largest buyer was Millennium Management, adding an estimated $14.1M. The largest seller was Marshall Wace, cutting an estimated $12.1M.
- 164 institutional investors held BioLife Solutions (BLFS) as of Q1 2022, down from 169 in Q4 2021.
- Funds reported $797M of BioLife Solutions stock for Q1 2022, down 39% quarter-over-quarter.
- 30 funds opened new BioLife Solutions positions in Q1 2022 and 34 closed out, a net change of -4 holders.
- The largest BioLife Solutions buyer in Q1 2022 was Millennium Management, an estimated $14.1M added.
- The largest BioLife Solutions seller in Q1 2022 was Marshall Wace, an estimated $12.1M sold.
Based on aggregated 13F filings for Q1 2022.